Device / Technology News

RSS

Office-based ESWT for treatment of foot pain

Dr. Ed Davis announced that he is now offering office-based extracorporeal shock wave therapy for the treatment of foot pain, particularly heel pain caused by plantar fasciitis (plantar fash-e-i-tis).

20 May 2010

Ingenix TrendView solution helps companies better understand, manage employee medical costs

Ingenix is launching Ingenix TrendView, an affordable, easy-to-use desktop solution designed to help companies better understand and manage a critical expense category - employee medical costs. Ingenix TrendView provides graphical views of consolidated employee benefits usage, enables scenario modeling, and uncovers opportunities for reducing medical costs and improving employee health.

20 May 2010

Milliman's CareWebQI interactive software tools interfaced with TriZetto's CareAdvance Enterprise 4.6 application

Healthcare payors can now use Milliman's CareWebQI® interactive software tools within The TriZetto Group's CareAdvance Enterprise® 4.6 application. A newly developed interface embeds guideline-based decision-making in the CareAdvance™ application workflow.

20 May 2010

BIOCIUS and Agilent launch RF360 High Resolution System for high-throughput screening of in vitro ADME assays

BIOCIUS Life Sciences, Inc. and Agilent Technologies Inc. today announced the launch of the RF360 High Resolution System for high-throughput screening of in vitro ADME assays. Combining the accurate mass capabilities of Agilent's time-of-flight (TOF) mass spectrometers and the unprecedented sample processing speed of RapidFire® technology, the instrument revolutionizes in vitro ADME analysis by eliminating the method development bottleneck in drug discovery.

From Evident Corporation - Life Sciences 20 May 2010

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.

20 May 2010

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions, Inc., announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate update.

20 May 2010

EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks

The supercomputer Cadmos, installed at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in August of 2009, has bared one of its first fruits: the Laboratory of Multiscale Modeling of Materials has recently developed a computer program the accurately models the complex system of blood flow in the heart for individuals at an unheard-of precision of ten millionths of a meter or ten microns.

20 May 2010

Cato Research to provide etrials EDC solution through Merge Healthcare's technology transfer program

Merge Healthcare, a leading Health IT solutions provider, announced today that it was selected by Cato Research Ltd. to provide the proprietary etrials EDC solution through Merge's technology transfer program. This new agreement expands Merge's partnership with CATO to provide additional technology for clinical trials management, as well as extending the relationship for an additional five years.

20 May 2010

Vanderbilt University orders Bruker's AVANCE III 900 US2 NMR spectrometer

Bruker, the leader in analytical magnetic resonance instrumentation, announces a major multi-systems NMR order from Vanderbilt University, including an ultra-high field AVANCE™ III 900 US2 NMR spectrometer. This purchase was made possible in large part by the American Recovery and Reinvestment Act. Vanderbilt will use these NMR instruments for a broad range of biophysical and structural analyses in biomedical research, as well as for cancer drug discovery using fragment-based approaches and structure-based drug design.

20 May 2010

Prolifiq conducts workshop on driving sales activity with systematic adherance to regulations

As the medical device industry gathers at Sales and Marketing Excellence 2010, Prolifiq, the leading provider of Sales Content Management software, offers medical device companies a solution to promote and sell in this highly regulated environment.

20 May 2010

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.

20 May 2010

Stockell Healthcare Systems launches new website

Stockell Healthcare Systems, Inc. is pleased to announce the unveiling of its new website at www.stockell.com.

20 May 2010

New study uses NMR in drug design

A new study by a team of researchers led by Jeffrey Peng, assistant professor of chemistry and biochemistry at the University of Notre Dame, is using Nuclear Magnetic Resonance, to move drug design into groundbreaking consideration of the dynamic flexibility of drugs and their targets.

20 May 2010

Boston University biomedical engineers develop new nanopore method for DNA sequencing

Sequencing DNA could get a lot faster and cheaper - and thus closer to routine use in clinical diagnostics - thanks to a new method developed by a research team based at Boston University. The team has demonstrated the first use of solid state nanopores - tiny holes in silicon chips that detect DNA molecules as they pass through the pore - to read the identity of the four nucleotides that encode each DNA molecule.

20 May 2010

Dynamic testing approach for HIV/AIDS diagnostics

A relatively simple electronic gadget could speed up HIV/AIDS diagnostics and improve accuracy particularly in parts of the world with very limited access to healthcare workers. The device is described in the International Journal of Biomedical Engineering and Technology.

20 May 2010

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

In non-sleepy patients with obstructive sleep apnea, treatment with continuous positive airway pressure can reduce the incidence of cardiovascular events and hypertension, according to researchers from Spain.

20 May 2010

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

bitop AG, which specializes in the development and marketing of Ectoin-containing medical devices, announces that Ectoin significantly reduces nanoparticle-induced inflammatory reaction in rat lungs, one of the animal models for chronic obstructive pulmonary disease. It is the first time that Ectoin has been shown to have such an effect on nanoparticle-induced lung inflammation.

20 May 2010

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

Patients with suspected obstructive sleep apnea may no longer have to spend an expensive and uncomfortable night at a sleep center to monitor their sleep-disordered breathing. According to new research, those who performed sleep testing in their home with portable monitors showed similar improvements after three months of treatment with continuous positive airway pressure in daytime function as compared to patients who underwent overnight testing in a sleep center.

20 May 2010

New Agilent SurePrint G3 Gene Expression Microarrays introduced

Agilent Technologies Inc. today introduced Agilent SurePrint G3 Gene Expression Microarrays, providing up to one million features per standard 1-by-3-inch slide for added throughput, unique coverage which includes both coding and non-coding RNA, and cost effectiveness.

20 May 2010

Stryker resolves FDA Warning Letters

Stryker Corporation today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that the actions undertaken to address issues raised in two Warning Letters received in 2007 and 2009 are sufficient.

From Stryker 20 May 2010

Device / Technology News

Office-based ESWT for treatment of foot pain

Ingenix TrendView solution helps companies better understand, manage employee medical costs

Milliman's CareWebQI interactive software tools interfaced with TriZetto's CareAdvance Enterprise 4.6 application

BIOCIUS and Agilent launch RF360 High Resolution System for high-throughput screening of in vitro ADME assays

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

BioLife Solutions first-quarter revenue up 36% to $513,000

EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks

Cato Research to provide etrials EDC solution through Merge Healthcare's technology transfer program

Vanderbilt University orders Bruker's AVANCE III 900 US2 NMR spectrometer

Prolifiq conducts workshop on driving sales activity with systematic adherance to regulations

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

Stockell Healthcare Systems launches new website

New study uses NMR in drug design

Boston University biomedical engineers develop new nanopore method for DNA sequencing

Dynamic testing approach for HIV/AIDS diagnostics

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

Home portable monitor testing can be used to diagnose, manage patients with OSA: Study

New Agilent SurePrint G3 Gene Expression Microarrays introduced

Stryker resolves FDA Warning Letters

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News